Overview

Postpartum Hemorrhage Prevention in Patients With Preeclampsia (PHP3 Study)

Status:
Completed
Trial end date:
2019-07-17
Target enrollment:
Participant gender:
Summary
Evaluation of the efficacy of postpartum 24 hour oxytocin infusion to reduce blood loss in patients with pre-eclampsia (PE)
Phase:
Early Phase 1
Details
Lead Sponsor:
University of Colorado, Denver
Treatments:
Oxytocin